Jagsonpal Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex - MarketsMojo
JAGSNPHARM | 636.65 9.80 1.52% |
Under 61% of Jagsonpal Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Jagsonpal Pharmaceuticals Limited stock suggests that many investors are alarmed at this time. Jagsonpal Pharmaceuticals' investing sentiment shows overall attitude of investors towards Jagsonpal Pharmaceuticals Limited.
Jagsonpal |
Jagsonpal Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex MarketsMojo
Read at news.google.com
Jagsonpal Pharmaceuticals Fundamental Analysis
We analyze Jagsonpal Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jagsonpal Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jagsonpal Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Jagsonpal Pharmaceuticals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Jagsonpal Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jagsonpal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jagsonpal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jagsonpal Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Jagsonpal Pharmaceuticals Related Equities
TCS | Tata Consultancy | 0.51 | ||||
RELIANCE | Reliance Industries | 0.04 | ||||
HDFCBANK | HDFC Bank | 0.16 | ||||
BHARTIARTL | Bharti Airtel | 0.19 |
Complementary Tools for Jagsonpal Stock analysis
When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |